Skip to main content

Table 3 Hazard ratios for clinical outcomes according to AFP normalization in propensity score matched cohorts

From: Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis

Outcome (n = 50) HR* (95 % CI) p-value
OS 2.823 (1.205-6.612) 0.017
PFS 1.894 (1.002-3.578) 0.049
  1. Abbreviations: HR hazard ratio, CI confidence interval, OS overall survival, PFS progression-free survival
  2. *HRs for the AFP non-normalized group compared with the AFP normalized group